Found: 17
Select item for more details and to access through your institution.
Development of CDK2 and CDK5 Dual Degrader TMX‐2172.
- Published in:
- Angewandte Chemie, 2020, v. 132, n. 33, p. 13969, doi. 10.1002/ange.202004087
- By:
- Publication type:
- Article
A kinase-independent role for CDK8 in BCR-ABL1<sup>+</sup> leukemia.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-12656-x
- By:
- Publication type:
- Article
CDK12 loss in cancer cells affects DNA damage response genes through premature cleavage and polyadenylation.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-09703-y
- By:
- Publication type:
- Article
Synergistic Anti-Tumor Effect of Combining Selective CDK7 and BRD4 Inhibition in Neuroblastoma.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2021.773186
- By:
- Publication type:
- Article
Corrigendum: Small genomic insertions form enhancers that misregulate oncogenes.
- Published in:
- Nature Communications, 2017, v. 8, n. 6, p. 15797, doi. 10.1038/ncomms15797
- By:
- Publication type:
- Article
Small genomic insertions form enhancers that misregulate oncogenes.
- Published in:
- Nature Communications, 2017, v. 8, n. 2, p. 14385, doi. 10.1038/ncomms14385
- By:
- Publication type:
- Article
Corrigendum: THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors.
- Published in:
- Nature Communications, 2017, v. 8, n. 2, p. 14747, doi. 10.1038/ncomms14747
- By:
- Publication type:
- Article
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors.
- Published in:
- Nature Communications, 2017, v. 8, n. 1, p. 14290, doi. 10.1038/ncomms14290
- By:
- Publication type:
- Article
P-099: Perturbation of CDK7 and super-enhancer driven transcriptional programs synergistically halts multiple myeloma cell proliferation.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S93, doi. 10.1016/S2152-2650(21)02233-3
- By:
- Publication type:
- Article
Development of CDK2 and CDK5 Dual Degrader TMX‐2172.
- Published in:
- Angewandte Chemie International Edition, 2020, v. 59, n. 33, p. 13865, doi. 10.1002/anie.202004087
- By:
- Publication type:
- Article
Release of Mps1 from kinetochores is crucial for timely anaphase onset.
- Published in:
- Journal of Cell Biology, 2010, v. 191, n. 2, p. 281, doi. 10.1083/jcb.201003038
- By:
- Publication type:
- Article
Covalent disruptor of YAP-TEAD association suppresses defective Hippo signaling.
- Published in:
- eLife, 2022, p. 1, doi. 10.7554/eLife.78810
- By:
- Publication type:
- Article
Targeting transcription regulation in cancer with a covalent CDK7 inhibitor.
- Published in:
- Nature, 2014, v. 511, n. 7511, p. 616, doi. 10.1038/nature13393
- By:
- Publication type:
- Article
Small-molecule kinase inhibitors provide insight into Mps1 cell cycle function.
- Published in:
- Nature Chemical Biology, 2010, v. 6, n. 5, p. 359, doi. 10.1038/nchembio.345
- By:
- Publication type:
- Article
Effects of the selective MPS1 inhibitor MPS1-IN-3 on glioblastoma sensitivity to antimitotic drugs.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Effects of the Selective MPSI Inhibitor MPSI-IN-3 on Glioblastoma Sensitivity to Antimitotic Drugs.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 17, p. 1322, doi. 10.1093/jnci/djt168
- By:
- Publication type:
- Article
Tivantinib (ARQ 197) efficacy is independent of MET inhibition in non-small-cell lung cancer cell lines.
- Published in:
- Molecular Oncology, 2015, v. 9, n. 1, p. 260, doi. 10.1016/j.molonc.2014.08.011
- By:
- Publication type:
- Article